should i switch from semaglutide to tirzepatide Switching dosage chart should i switch to tirzepatide

This approval is an important milestone for people living with obesity and cardiovascular disease, as the SELECT data demonstrated that Wegovy has the potential to prolong lives by addressing some of the leading causes of preventable deaths by reducing the risks of cardiovascular events.

In Study 7, at Week 64, the body weight was missing for 6.3% and 11.8% of patients randomized to WEGOVY tablets and placebo, respectively

Weight loss during the first month is often modest - some patients report 2-5 pounds, others report minimal changes

Happy one-year birthday to our adorable little collection of longs and shorts

This new study provides real-world evidence for its impact on Alzheimers disease, even though preclinical research has suggested that semaglutide may protect against neurodegeneration and neuroinflammation, Xu said in a release related to the study